1.The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581–7.
2.Hacke, W, Kaste, M, Fieschi, C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998; 352:1245–51.
3.Hacke, W, Kaste, M, Bluhmki, E, et al. ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359(13):1317–29.
4.The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997; 28:2109–18.
5.Fiorelli, M, Bastianello, S, von Kummer, R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999; 30:2280–4.
6.del Zoppo, G J, Higashida, R T, Furlan, A J, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998; 29:4–11.
7.Furlan, A, Higashida, R, Wechsler, L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282:2003–11.
8.IMS Study Investigators. Combined intravenous and intraarterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke. 2004; 35:904–11.
9.IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke. 2007; 38:2127–35.
10.Smith, W S, Sung, G, Starkman, S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005; 36:1432–8.
11.Smith, W S, Sung, G, Saver, J, et al. Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke. 2008; 39:1205–12.
12.Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009; 40:2761–8.
13.Saver, J L, Jahan, R, Levy, E I, et al. SWIFT Trialists. Solitaire Flow Restoration Device versus the Merci Retriever in Patients with Acute Ischaemic Stroke (SWIFT): A randomised, parallel-group, non-inferiority trial. Lancet. 2012; 380(9849):1241–9.
14.Nogueira, R G, Lutsep, H L, Gupta, R, et al. TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): A randomised trial. Lancet. 2012; 380(9849):1231–40.
15.Broderick, J P, Palesch, Y Y, Demchuk, A M, et al. Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013; 368(10):893–903.
16.Berkhemer, O A, Fransen, P S, Beumer, D, et al. MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015; 372(1):11–20.
17.Goyal, M, Demchuk, A M, Menon, B K, et al. ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 372(11):1019–30.
18.Campbell, B C, Mitchell, P J, Kleinig, T J, et al. EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015; 372(11):1009–18.
19.Alexandrov, A V, Black, S E, Ehrlich, L E, Caldwell, C B, Norris, J W. Predictors of hemorrhagic transformation occurring spontaneously and on anticoagulants in patients with acute ischemic stroke. Stroke. 1997; 28:1198–202.
20.Wang, X, Lo, E H. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol. 2003; 28:229–44.
21.Gasche, Y, Copin, J C, Sugawara, T, Fujimura, M, Chan, P H. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood–brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2001; 21:1393–400.
22.Khatri, R, Khatri, P, Khoury, J, et al. Microcatheter contrast injections during intra-arterial thrombolysis increase intracranial hemorrhage risk. J Neurointerv Surg. 2010; 2:115–19.
23.Demchuk, A M, Morgenstern, L B, Krieger, D W, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999; 30:34–9.
24.Natarajan, S K, Dandona, P, Karmon, Y, et al. Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. Clinical Article J Neurosurg. 2011; 114:1785–99.
25.Molina, C A, Alvarez-Sabin, J, Montaner, J, et al. Thrombolysis-related hemorrhagic infarction: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 2002; 33:1551–6.
26.Dubey, N, Bakshi, R, Wasay, M, Dmochowski, J. Early computed tomography hypodensity predicts hemorrhage after intravenous tissue plasminogen activator in acute ischemic stroke. J Neuroimaging. 2001; 11:184–8.
27.Barber, P A, Demchuk, A M, Zhang, J, Buchan, A M. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000; 355:1670–4.
28.Dzialowski, I, Hill, M D, Coutts, S B, et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke. 2006; 37:973–8.
29.Hill, M D, Rowley, H A, Adler, F, et al. PROACT-II Investigators. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke. 2003; 34:1925–31.
30.Hill, M D, Demchuk, A M, Tomsick, T A, Palesch, Y Y, Broderick, J P. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. Am J Neuroradiol. 2006; 27:1612–16.
31.Hill, M D, Demchuk, A M, Goyal, M, et al. IMS3 Investigators. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke. 2014; 45(2):444–9.
32.Whiteley, W N, Slot, K B, Fernandes, P, Sandercock, P, Wardlaw, J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke. 2012; 43(11):2904–9.
33.Henninger, N, Lin, E, Baker, S P, et al. Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion. Cerebrovasc Dis. 2012; 33(6):525–31.
34.Orrison, W W Jr, Snyder, K V, Hopkins, L N, et al. Whole-brain dynamic CT angiography and perfusion imaging. Clin Radiol. 2011; 66:566–74.
35.Gasparotti, R, Grassi, M, Mardighian, D, et al. Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: Predictive value of infarct core size on clinical outcome. Am J Neuroradiol. 2009; 30:722–7.
36.Bhatt, A, Vora, N A, Thomas, A J, et al. Lower pre-treatment cerebral blood volume increases hemorrhagic risks after intra-arterial revascularization in acute stroke. Neurosurgery. 2008; 63:874–9.
37.Liebeskind, D S, Tomsick, T A, Foster, L D, et al. IMS III Investigators. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014;45(3):759–64.
38.Kidwell, C S, Chalela, J A, Saver, J L, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 2004; 292:1823–30.
39.Kakuda, W, Thijs, V N, Lansberg, M G, et al. DEFUSE Investigators. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology. 2005; 65:1175–8.
40.Fiehler, J, Albers, G W, Boulanger, J M, et al. MR Stroke Group. Bleeding risk analysis in stroke imaging before thrombolysis. Stroke. 2007; 38:2738–44.
41.Soo, Y O, Siu, D Y, Abrigo, J, et al. Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention. Stroke. 2012; 43(6):1532–6.
42.Shi, Z S, Loh, Y, Liebeskind, D S, Saver, J L, et al. Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke. Stroke. 2012; 43(7):1806–11.
43.del Zoppo, G J, von Kummer, R, Hamann, G F. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. JNNP. 1998; 65:1–9.
44.Warach, S, Latour, L L. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood–brain barrier disruption. Stroke. 2004; 35(suppl I):2659–61.
45.Lansberg, M G, Thijs, V N, Bammer, R, et al. DEFUSE Investigators. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke. 2007; 38:2275–8.
46.Singer, O C, Kurre, W, Humpich, M C, et al. MR Stroke Study Group Investigators. Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS. Stroke. 2009; 40(8):2743–8.
47.Deguchi, I, Dembo, T, Fukuoka, T, et al. Usefulness of MRA-DWI mismatch in neuroendovascular therapy for acute cerebral infarction. Eur J Neurol. 2012; 19(1):114–20.
48.Yoon, W, Seo, J J, Kim, J K, et al. Contrast enhancement and contrast extravasation on computed tomography after intra-arterial thrombolysis in patients with acute ischemic stroke. Stroke. 2004; 35:876–81.
49.Broderick, J, Connolly, S, Feldmann, E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007; 38:2001–23.
50.Mokin, M, Kass-Hout, T, Kass-Hout, O, Zivadinov, R, Mehta, B. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2012; 21(8):852–9.
51.Ko, Y, Park, J H, Yang, M H, et al. The significance of blood pressure variability for the development of hemorrhagic transformation in acute ischemic stroke. Stroke. 2010; 41:2512–18.
52.Goldstein, J N, Marrero, M, Masrur, S, et al. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol. 2010; 67:965–9.
53.Mendelow, A D, Gregson, B A, Fernandes, H M, et al. STICH investigators. Early versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet. 2005; 365:387–97.
54.Williams, A, Sittampalam, M, Barua, N, Mohd Nor, A. Case series of post-thrombolysis patients undergoing hemicraniectomy for malignant anterior circulation ischaemic stroke. Cardiovasc Psychiatry Neurol. 2011; 254569.
55.Alshekhlee, A, Horn, C, Jung, R, Alawi, A A, Cruz-Flores, S. In-hospital mortality in acute ischemic stroke treated with hemicraniectomy in US hospitals. J Stroke Cerebrovasc Dis. 2011; 20:196–201.
56.Fargen, K M, Hoh, B L, Fautheree, G L, et al. Aggressive intervention to treat a young woman with intracranial hemorrhage following unsuccessful intravenous thrombolysis for left middle cerebral artery occlusion. Case report. J Neurosurg. 2011; 115:359–63.